Research in the microbiome field has highlighted the critical role of
probiotics in supporting various aspects of human health, including
gastrointestinal, cardiovascular, and mental health, as well as metabolism and
nutrition. Tablets India has been at the forefront of this research, developing
innovative probiotic solutions targeting specific health concerns, such as
women’s health digestive wellness, and others.
Our focus on R&D and unique formulations has led to the launch of
several successful products, establishing them as market leaders. The company’s
holistic approach to product development includes strain-specific research,
ensuring the efficacy and superior performance of our products.
Tablets India's product range is diverse, including dry syrups, lozenges,
and unique delivery platforms like sachet-in-sachet and capsule-in-capsule
systems. our latest launch, Tummysoft-AD, is India’s first digestive-specific
probiotic combined with digestive enzymes in a mouth-melt formulation. Such
innovations reflect Tablets India’s commitment to addressing evolving customer
Bifilac, our flagship product, has remained one of India’s top-selling
probiotics. The introduction of Bifilac Clausi, a 100% Made in India Bacillus
clausii probiotic, marks a significant achievement in self-reliance and
The Indian probiotics market is competitive, yet Tablets India has
distinguished itself through its evidence-based approach and development of
strain-specific probiotics. Collaborations with global leaders in the
probiotics space have bolstered our market position. Our transparent
communication and customized solutions approach has been key in maintaining
and acquiring new partnerships.
Future Outlook: Expanding Horizons in Probiotic Solutions
Looking ahead, Tablets India is poised for further growth. With a focus on
developing easy-to-consume and effective probiotic products, we are set to
introduce several first-in-India formulations. Our continuous innovation and
robust product pipeline position us as a dynamic and forward-thinking leader in
the probiotic industry in India.
Conclusion: A Leader in Probiotic Innovation
In conclusion, Tablets India's array of innovative probiotic solutions,
targeting various health concerns and physiological functions, exemplifies our leadership in the industry. our success in
developing market-leading probiotic products and earning Frost & Sullivan’s
2023 India Product Leadership Award showcases our unwavering commitment to
advancing health and wellness through probiotics.